Nutex Health Inc.
NUTX
$90.28
-$15.06-14.30%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -41.12% | 239.87% | 220.69% | 213.98% | 269.77% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -41.12% | 239.87% | 220.69% | 213.98% | 269.77% |
| Cost of Revenue | -10.71% | 107.91% | 132.33% | 66.37% | 103.02% |
| Gross Profit | -62.08% | 494.61% | 380.45% | 760.56% | 752.19% |
| SG&A Expenses | -389.15% | 107.24% | 761.53% | 332.72% | 260.66% |
| Depreciation & Amortization | -1.78% | 0.62% | 15.77% | 21.64% | 12.78% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -97.38% | 100.03% | 228.03% | 98.67% | 118.53% |
| Operating Income | 29.44% | 1,192.30% | 181.36% | 5,462.83% | 2,703.19% |
| Income Before Tax | -76.17% | 4,903.84% | 507.89% | 46,952.63% | 453.81% |
| Income Tax Expenses | 1.46% | 491.93% | 748.77% | 5,133.33% | 405.21% |
| Earnings from Continuing Operations | -83.31% | 1,451.00% | 436.35% | 9,473.80% | 459.07% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 87.40% | -2,448.61% | -902.99% | -16,723.03% | -869.92% |
| Net Income | -80.79% | 730.80% | -4,761.81% | 5,928.85% | 294.87% |
| EBIT | 29.44% | 1,192.30% | 181.36% | 5,462.83% | 2,703.19% |
| EBITDA | 28.06% | 798.87% | 135.88% | 1,421.52% | 1,264.90% |
| EPS Basic | -85.83% | 580.08% | -3,932.79% | 5,083.62% | 257.53% |
| Normalized Basic EPS | 107.74% | 1,025.07% | -587.07% | 15,292.40% | 676.00% |
| EPS Diluted | -86.16% | 550.35% | -3,932.79% | 4,051.00% | 250.63% |
| Normalized Diluted EPS | 121.00% | 963.70% | -587.07% | 12,924.56% | 641.43% |
| Average Basic Shares Outstanding | 35.59% | 31.40% | 20.63% | 16.90% | 23.71% |
| Average Diluted Shares Outstanding | 27.45% | 40.74% | 20.63% | 38.16% | 31.61% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | 1.26% | -- |